JP2024527565A5 - - Google Patents
Info
- Publication number
- JP2024527565A5 JP2024527565A5 JP2024500151A JP2024500151A JP2024527565A5 JP 2024527565 A5 JP2024527565 A5 JP 2024527565A5 JP 2024500151 A JP2024500151 A JP 2024500151A JP 2024500151 A JP2024500151 A JP 2024500151A JP 2024527565 A5 JP2024527565 A5 JP 2024527565A5
- Authority
- JP
- Japan
- Prior art keywords
- amino
- chloro
- pyrimidine
- tetrahydroisoquinoline
- methoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN202121030204 | 2021-07-06 | ||
| IN202121030204 | 2021-07-06 | ||
| PCT/IB2022/056248 WO2023281417A1 (en) | 2021-07-06 | 2022-07-06 | Pyrimidine compounds for use as map4k1 inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024527565A JP2024527565A (ja) | 2024-07-25 |
| JP2024527565A5 true JP2024527565A5 (cg-RX-API-DMAC7.html) | 2024-09-11 |
Family
ID=82703212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024500151A Pending JP2024527565A (ja) | 2021-07-06 | 2022-07-06 | Ｍａｐ４ｋ１阻害物質として使用するためのピリミジン化合物 |
Country Status (14)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024231875A1 (en) | 2023-05-09 | 2024-11-14 | Glenmark Specialty S.A. | Hpk1 inhibitor for use in the treatment of cancer |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2792979T3 (es) * | 2013-08-22 | 2020-11-12 | Jubilant Biosys Ltd | Compuestos de pirimidina sustituidos, composiciones y aplicaciones médicas de los mismos |
| WO2018102366A1 (en) * | 2016-11-30 | 2018-06-07 | Ariad Pharmaceuticals, Inc. | Anilinopyrimidines as haematopoietic progenitor kinase 1 (hpk1) inhibitors |
| AU2020406824A1 (en) * | 2019-12-16 | 2022-08-11 | Korea Research Institute Of Chemical Technology | Novel pyrimidine derivative and use thereof |
-
2022
- 2022-07-06 CA CA3223874A patent/CA3223874A1/en active Pending
- 2022-07-06 EP EP22747756.9A patent/EP4367123A1/en not_active Withdrawn
- 2022-07-06 US US17/912,729 patent/US12577267B2/en active Active
- 2022-07-06 AU AU2022305807A patent/AU2022305807B2/en not_active Expired - Fee Related
- 2022-07-06 PE PE2023003341A patent/PE20240585A1/es unknown
- 2022-07-06 WO PCT/IB2022/056248 patent/WO2023281417A1/en not_active Ceased
- 2022-07-06 CN CN202280048104.2A patent/CN117730083A/zh active Pending
- 2022-07-06 KR KR1020237044454A patent/KR20240012538A/ko not_active Ceased
- 2022-07-06 IL IL309342A patent/IL309342A/en unknown
- 2022-07-06 MX MX2023015246A patent/MX2023015246A/es unknown
- 2022-07-06 JP JP2024500151A patent/JP2024527565A/ja active Pending
-
2023
- 2023-12-19 CL CL2023003791A patent/CL2023003791A1/es unknown
-
2024
- 2024-01-24 CO CONC2024/0000572A patent/CO2024000572A2/es unknown
- 2024-01-26 EC ECSENADI20247193A patent/ECSP24007193A/es unknown